サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：エストロゲンとプロゲステロンの市場2022-2028
市場調査レポート
商品コード
1215662

エストロゲンとプロゲステロンの市場2022-2028

Estrogen and Progesterone Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
エストロゲンとプロゲステロンの市場2022-2028
出版日: 2023年01月14日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エストロゲンとプロゲステロンの世界市場は、予測期間中に14.1%というかなりのCAGRで成長すると予想されています。天然有機ホルモンバランス薬の傾向の高まりは、市場開拓の新たな機会を生み出しています。天然プロゲステロンベースの製品は、大豆またはDioscorea villosaと呼ばれるメキシコの野生で食べられないヤマイモから作られた併用薬物療法に含まれます。クリノンとプロメトリウムは、市場で最も天然プロゲステロンの医薬品です。本レポートではさらに、市場の成長に直接的または間接的に影響を与えている一次的要因だけでなく二次的要因もすべて分析します。

世界のエストロゲンとプロゲステロン市場は、種類と流通チャネルに基づいて区分されています。タイプに基づいて、市場はアグレプリストン、ミフェプリストン、アソプリズニル、テラプリストン、ウリプリスタルアセテートに区分されます。販売チャネルでは、薬局、病院、クリニックに細分化されます。これらの流通チャネルのうち、病院は消費者の間で最も信頼されている医薬品購入先であるため、市場で大きなシェアを占めています。しかし、OTC医薬品の増加傾向や薬局が提供する魅力的な割引が、薬局の市場を大きく牽引すると思われます。上記のセグメントは、要件に応じてカスタマイズすることも可能です。

地域的には、エストロゲンとプロゲステロンの世界市場は、北米、欧州、アジア太平洋地域、その他の地域に区分されます。また、ご要望に応じて、特定の地域や国レベルでの市場分析も可能です。UAEやサウジアラビアを含むほとんどの国では、性転換手術が禁止されていました。性同一性障害の患者は、政府の医療委員会から承認を得た場合のみ、性転換治療や手術を受けることができます。ガルフニュースによると、過去36年間に約2,000人のサウジアラビア人が性転換手術を受けています。こうした政府の規制は、エストロゲンとプロゲステロンの市場にさまざまな影響を及ぼしています。

目次

第1章 レポート概要

  • 現在の産業分析と成長性の展望
  • エストロゲンとプロゲステロンの世界市場に対するCOVID-19の影響
  • エストロゲンとプロゲステロンの世界市場の回復シナリオ
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場の概要とインサイト

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • レコメンデーション
    • まとめ

第3章 競合情勢

  • 主要企業分析
    • AstraZeneca, Ltd.
    • Teva Pharmaceutical Industries, Ltd.
    • Abbott Healthcare Products B.V.
    • Novartis International AG
  • 主要戦略分析

第4章 市場セグメンテーション

  • エストロゲンとプロゲステロンの世界市場：タイプ別
    • アグリプリストン
    • ミフェプリストン
    • アソプリスニル
    • テラプリストン
    • ウリプリスタルアセテート
  • エストロゲンとプロゲステロンの世界市場：流通チャネル別
    • 薬局
    • 病院・診療所

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Aspen Pharmacare Australia Pty Ltd.
  • Bayer AG
  • Besins Healthcare Benelux
  • Bluebell pharma Group Co.
  • Dr.Kade Pharmazeutische Fabrik GmbH
  • Eli Lilly Nederland B.V.
  • F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
  • Gedeon Richter Plc
  • Jenapharm GmbH & Co. KG
  • MERCK SERONO, Ltd.
  • N.V.Organon
  • Orion Corp.
  • Pfizer, Inc.
  • Shanghai Yijing Industrial Co., Ltd.
  • Sofgen Pharmaceuticals
  • Virtus Pharmaceuticals LLC
図表

LIST OF TABLES

  • 1. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL AGLEPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL MIFEPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ASOPRISNIL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TELAPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ULIPRISTAL ACETATE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 8. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA PHARMACY RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA HOSPITAL AND CLINICS RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 15. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 17. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL AGLEPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 3. GLOBAL MIFEPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL ASOPRISNIL MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL TELAPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL ULIPRISTAL ACETATE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
  • 8. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA PHARMACY SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA HOSPITAL AND CLINICS SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. US ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. CANADA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. UK ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. FRANCE ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. GERMANY ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. ITALY ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. SPAIN ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. REST OF EUROPE ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. INDIA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. CHINA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. JAPAN ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026718

Title:Global Estrogen and Progesterone Market Size, Share, and Trends Analysis Report by Type (Aglepristone, Mifepristone, Asoprisnil, Telapristone, and Ulipristal Acetate) and By Distribution Channel (Pharmacy and Hospital and Clinics), Forecast Period (2022-2028).

The global estrogen and progesterone market is anticipated to grow at a considerable CAGR of 14.1% during the forecast period. The rising trend of natural and organic hormone balancing drugs is generating new opportunities for market development. Natural progesterone-based products are inclusive of combination drug therapies made from soybeans or a wild, inedible Mexican yam called Dioscorea villosa. Crinone and Prometrium are the most natural progesterone drugs in the market. This report will further analyze all the primary as well as secondary factors that are directly or indirectly impacting the growth of the market.

The global estrogen and progesterone market is segmented based on the type and distribution channel. Based on the type, the market is segmented into aglepristone, mifepristone, asoprisnil, telapristone, and ulipristal acetate. Based on the distribution channel, the market is sub-segmented into pharmacy, and hospital and clinics. Among these distribution channels, the hospital segment holds the major share in the market as it is the most trusted source for drug purchases among consumers. However, the rising trend of OTC drugs and attractive discounts offered by pharmacies will significantly drive the pharmacy segment in the market. The above-mentioned segments can also be customized as per the requirements.

Geographically, the global estrogen and progesterone market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The market can also be analyzed for a particular region or country level as per the requirement. Most nations, including the UAE and Saudi Arabia, had banned sex-change surgeries. Patients with gender dysphoria can only undergo sex correction therapies or surgeries if they get approval from the governmental medical commission. As per the Gulf News, around 2,000 Saudis had undergone sex correction surgeries in the past 36 years. Such government regulations have a mixed impact on the estrogen and progesterone market.

The major companies serving the global estrogen and progesterone market include AstraZeneca Ltd., Teva Pharmaceutical Industries Ltd., Abbott Healthcare Products B.V., Novartis International AG, Pfizer Inc., Merck Serono Ltd., and Bayer AG, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Bayer AG announced the acquisition of KanDy Therapeutics Inc. in August 2020, which aids in the expansion of Bayer's women's drug pipeline by adding KanDy's menopause drug to its portfolio.

Research Methodology

The market study of the global estrogen and progesterone market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Estrogen and Progesterone Market Research and Analysis by Type.
  • Global Estrogen and Progesterone Market Research and Analysis by Distribution Channel.

The Report Covers:

  • Comprehensive research methodology of the global estrogen and progesterone market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global estrogen and progesterone market.
  • Insights about market determinants that are stimulating the global estrogen and progesterone market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Estrogen and Progesterone Market
  • Recovery Scenario of Global Estrogen and Progesterone Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. AstraZeneca, Ltd.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Teva Pharmaceutical Industries, Ltd.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Abbott Healthcare Products B.V.
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. Novartis International AG
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Estrogen and Progesterone Market by Type
    • 4.1.1. Aglepristone
    • 4.1.2. Mifepristone
    • 4.1.3. Asoprisnil
    • 4.1.4. Telapristone
    • 4.1.5. Ulipristal Acetate
  • 4.2. Global Estrogen and Progesterone Market by Distribution Channel
    • 4.2.1. Pharmacy
    • 4.2.2. Hospital and Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aspen Pharmacare Australia Pty Ltd.
  • 6.2. Bayer AG
  • 6.3. Besins Healthcare Benelux
  • 6.4. Bluebell pharma Group Co.
  • 6.5. Dr.Kade Pharmazeutische Fabrik GmbH
  • 6.6. Eli Lilly Nederland B.V.
  • 6.7. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
  • 6.8. Gedeon Richter Plc
  • 6.9. Jenapharm GmbH & Co. KG
  • 6.10. MERCK SERONO, Ltd.
  • 6.11. N.V.Organon
  • 6.12. Orion Corp.
  • 6.13. Pfizer, Inc.
  • 6.14. Shanghai Yijing Industrial Co., Ltd.
  • 6.15. Sofgen Pharmaceuticals
  • 6.16. Virtus Pharmaceuticals LLC